Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Quotient sells $39mm through private placement of shares and warrants

Executive Summary

Diagnostics firm Quotient Ltd. grossed $39mm through the private sale of 7.86mm ordinary shares at $4.64 (a 3% discount), and 500k pre-funded warrants (exercisable for 550k shares) at $4.755 per warrant. Buyers also received warrants to purchase 8.4mm more ordinary shares at an exercise price of $5.80. Investors included Perceptive Life Sciences, Highbridge Capital Management, Polar Capital, Cormorant, Sio Capital, Galen Partners, and individual backers. Proceeds will support work on the company's transfusion diagnostics platform MosaiQ.
Deal Industry
  • In Vitro Diagnostics
    • Hematology, Coagulation
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies